论文部分内容阅读
目的:评价我院2002年8月至2004年9月急诊收治的急性心肌梗死患者开展急诊绿色通道急诊静脉溶栓治疗的临床疗效。方法:48例患者随机选择尿激酶、重组组织型纤溶酶原激活剂、重组链激酶给予急性心肌梗死静脉溶栓治疗。结果:尿激酶再通率83.33%(30/36),重组组织型纤溶酶原激活剂再通率88.89%(7/8),重组链激酶再通率66.67%(2/3),无1例出血、过敏并发症,1例死亡。结论:对急性心肌梗死患者,开展急诊绿色通道静脉溶栓治疗,在急诊溶栓准备时间仅用了21±8min,比以往溶栓提前2～6h,减少院内溶栓前时间延误,提高了静脉溶栓的再通率,是提高 AMI 救治成功率的关键环节。
Objective: To evaluate the clinical efficacy of emergency green channel emergency thrombolysis in patients with acute myocardial infarction admitted to our hospital from August 2002 to September 2004. Methods: 48 patients were randomly selected urokinase, recombinant tissue-type plasminogen activator, recombinant streptokinase given intravenous thrombolytic therapy of myocardial infarction. Results: The recanalization rate of urokinase was 83.33% (30/36), the recanalization rate of recombinant tissue plasminogen activator was 88.89% (7/8), the recombination rate of recombinant streptokinase was 66.67% (2/3) 1 case of bleeding, allergic complications, 1 case of death. Conclusion: Emergency intravenous thrombolysis in patients with acute myocardial infarction has only 21 ± 8 minutes in the preparation of emergency thrombolysis, which is 2 to 6 hours earlier than previous thrombolysis, which can reduce the time delay before thrombolysis in the hospital and increase the incidence of venous thrombosis Thrombolysis recanalization rate, is to improve the success rate of AMI treatment key link.